GlassScriptPhysician profile
Antonie Morgan
NPI 1609042381
$877.74
in general payments reported to CMS, 2019-2025
10 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $274 · 2022: $135 · 2023: $137 · 2024: $179 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $469.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $231.94 | 2021-2024 | Verquvo, Vaxneuvance, Gardasil 9 |
| E.R. Squibb & Sons, L.L.C. | $127.24 | 2024-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $126.56 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $102.86 | 2022-2025 | Farxiga, Andexxa, Lokelma |
| Amarin Pharma, INC. | $84.32 | 2021 | |
| Janssen Pharmaceuticals, INC | $55.55 | 2021 | |
| Azurity Pharmaceuticals, INC. | $50.53 | 2023-2024 | Edarbi, Edarbi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.46 | 2024-2025 | Jardiance |
| Pfizer INC. | $34.89 | 2023-2024 | |
| Cvrx, INC. | $26.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonie Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.